Figure 3.
Figure 3. Following T-cell-depleted D-/R+ alloSCT, a primary HCMV-specific CD8+ T-cell response developed in recipient 05 within 12 months. An HCMV pp65495-503-specific CD8+ T-cell clone (clone 5.2) was obtained from the HCMV-seropositive recipient at 21 months after T-cell-depleted alloSCT. The clone was not detected in the donor or in recipient 05 prior to transplantation. Following an episode of HCMV retinitis at 5 months, the clone was first detected in recipient 05 at 12 months after alloSCT. The retinitis resolved following ganciclovir therapy, and subsequent weekly blood tests for HCMV DNA were negative.

Following T-cell-depleted D-/R+ alloSCT, a primary HCMV-specific CD8+ T-cell response developed in recipient 05 within 12 months. An HCMV pp65495-503-specific CD8+ T-cell clone (clone 5.2) was obtained from the HCMV-seropositive recipient at 21 months after T-cell-depleted alloSCT. The clone was not detected in the donor or in recipient 05 prior to transplantation. Following an episode of HCMV retinitis at 5 months, the clone was first detected in recipient 05 at 12 months after alloSCT. The retinitis resolved following ganciclovir therapy, and subsequent weekly blood tests for HCMV DNA were negative.

Close Modal

or Create an Account

Close Modal
Close Modal